Third Harmonic Bio, Inc. (THRD)
NASDAQ: THRD · Real-Time Price · USD
5.43
+0.01 (0.18%)
At close: Jul 3, 2025, 1:00 PM
5.50
+0.07 (1.29%)
After-hours: Jul 3, 2025, 1:47 PM EDT
Third Harmonic Bio Market Cap
Third Harmonic Bio has a market cap or net worth of $245.04 million as of July 3, 2025. Its market cap has decreased by -55.11% in one year.
Market Cap
245.04M
Enterprise Value
-23.57M
1-Year Change
-55.11%
Ranking
Category
Stock Price
$5.43
Market Cap Chart
Since the IPO on September 15, 2022, Third Harmonic Bio's market cap has decreased from $657.80M to $245.04M, a decrease of -62.75%. That is a compound annual growth rate of -29.74%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 2, 2025 | 244.59M | -47.25% |
| Dec 31, 2024 | 463.65M | 4.71% |
| Dec 29, 2023 | 442.78M | 153.97% |
| Dec 30, 2022 | 174.34M | -73.50% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 699.59B |
| Johnson & Johnson | 374.29B |
| AbbVie | 336.94B |
| Novo Nordisk | 309.43B |
| UnitedHealth Group | 279.00B |
| Novartis AG | 243.28B |
| Abbott Laboratories | 233.33B |
| AstraZeneca | 219.33B |